855. Impact of FDA Black Box Warning on Fluoroquinolone and Alternative Antibiotic Use in Southeastern US Hospitals

BACKGROUND: Many antimicrobial stewardship programs have set goals to reduce the use of fluoroquinolones because of risks of causing C. difficile and other adverse safety events. The US Food and Drug Administration issued a black box label warning for fluoroquinolones in June 2016 recommending avoid...

Descripción completa

Detalles Bibliográficos
Autores principales: Yarrington, Michael, Anderson, Deverick J, Ashley, Elizabeth Dodds, Jones, Travis, Johnson, Melissa, Lokhnygina, Yuliya, Sexton, Daniel, Moehring, Rebekah W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252437/
http://dx.doi.org/10.1093/ofid/ofy209.040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252437/
http://dx.doi.org/10.1093/ofid/ofy209.040

Ejemplares similares